News

Tim Lowery Promoted to President of JSR Life Sciences, LLC

Sunnyvale, CA – June 18, 2019 – JSR Life Sciences, LLC announced today that Tim Lowery has assumed the role of president where he will oversee the Company’s global operations, which include JSR affiliate companies Crown Bioscience, KBI Biopharma, Inc., Medical & Biological Laboratories Co., LTD., Selexis SA and other affiliates throughout Europe and the Asia-Pacific region. 

Read more about Tim Lowery Promoted to President of JSR Life Sciences, LLC
Page unavailable for this region.
Page unavailable for this region.
Page unavailable for this region.
Page unavailable for this region.

JSR Announces the Opening of the JSR-Keio University Medical and Chemical Innovation Center

Tokyo – Nov. 21, 2017 – JSR Corporation announced today that it held the opening ceremony of the JSR-Keio University Medical and Chemical Innovation Center (JKiC) on October 28 at the Keio University Shinanomachi Campus.

Read more about JSR Announces the Opening of the JSR-Keio University Medical and Chemical Innovation Center

Webcast on the purification of antibody fragments

On Wednesday September 13th, our colleague Gerald Platteau gave a presentation about the purification of antibody fragments with Amsphere™ A3 protein A resin. 

He talked about:
·    Antibody fragment types that can be purified with protein A resin
·    Amsphere A3 binding sites in VHH single domain antibodies and VH domains
·    Dynamic binding capacity data of Amsphere A3 for different antibody (fragment) formats
·    Advantages of a Protein A resin for antibody fragment capture, compared to other resin types

Read more about Webcast on the purification of antibody fragments

JSR Agrees to Acquire Medical 3D Software Company Lexi Co., Ltd.

JSR Corporation (JSR) announced that it has agreed to acquire Lexi Co., Ltd. (Lexi) a medical 3D software company. Through this acquisition, JSR will establish a new business in life sciences by integrating Lexi's 3D software technology with JSR's 3D printing and materials technologies. The JSR Group is focused on creating novel value and capitalizing on the trend toward digitization in the medical and life sciences industries.

Read more about JSR Agrees to Acquire Medical 3D Software Company Lexi Co., Ltd.

JSR Life Sciences Expands Amsphere™ A3 Production Capacity

Tokyo, Japan - May 9, 2017 – JSR Life Sciences (JLS), the global life sciences focused division of JSR Corporation, today announced plans for expansion of its production capabilities of Amsphere™ A3 protein-A chromatography resin at JSR’s Belgium subsidiary, JSR Micro NV. This expansion will effectively increase its production capacity by 6 times and provide all-important redundancy in its manufacturing capability. 

Read more about JSR Life Sciences Expands Amsphere™ A3 Production Capacity

Pages